Inari Medical, Inc. revised revenue guidance for the year 2023. For the full year 2023, the company is raising revenue guidance to a range of $490 million to $493 million, an increase of $4.5 million at the midpoint from prior guidance range of $482 million to $492 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.29 USD | -1.49% | +8.94% | -28.70% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.70% | 2.73B | |
+73.64% | 12.42B | |
-19.88% | 7.94B | |
+2.90% | 6.17B | |
+13.65% | 5.5B | |
+40.00% | 5.01B | |
-15.25% | 4.88B | |
-16.42% | 4.2B | |
+48.49% | 2.27B | |
+0.50% | 2.04B |
- Stock Market
- Equities
- NARI Stock
- News Inari Medical, Inc.
- Inari Medical, Inc. Revises Revenue Guidance for the Year 2023